Identification of GSK3 as a Potential Therapeutic Entry Point for Epilepsy

doi 10.1021/acschemneuro.8b00281.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Identification of DEK as a Potential Therapeutic Target for Neuroendocrine Prostate Cancer

Oncotarget
Oncology
2014English

Is Mossy Fiber Sprouting a Potential Therapeutic Target for Epilepsy?

Frontiers in Neurology
Neurology
2018English

Stem Cells as a Potential Therapy for Epilepsy

Experimental Neurology
Developmental NeuroscienceNeurology
2013English

Silk Polymer-Based Adenosine Release: Therapeutic Potential for Epilepsy

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2008English

H-Channels as a Therapeutic Target in Epilepsy

Epilepsy Currents
Neurology
2003English

Identification of Pharmacological Chaperones as Potential Therapeutic Agents to Treat Phenylketonuria

Journal of Clinical Investigation
Medicine
2008English

Preclinical Evidence of Ghrelin as a Therapeutic Target in Epilepsy

Oncotarget
Oncology
2017English

P202 AS a Potential Therapeutic Gene for Breast Cancer

2002English

Exploring Internal Ribosome Entry Sites as Therapeutic Targets

Frontiers in Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy